GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
Suzhou Genhouse Bio Co., Ltd.
University Hospital, Ghent
Centre Georges Francois Leclerc
Massachusetts General Hospital
Kineta Inc.
Shanghai Yunying Medical Technology
Jules Bordet Institute
Centre Henri Becquerel
Wellmarker Bio
Revolution Medicines, Inc.
Imperial College London
Silverback Therapeutics
Shanghai Fengxian District Central Hospital
Blueprint Medicines Corporation
Hospices Civils de Lyon
SpeciCare
Petra Pharma
University of Aarhus
Samyang Biopharmaceuticals Corporation
Instituto do Cancer do Estado de São Paulo
Critical Outcome Technologies Inc.
Sound Pharmaceuticals, Incorporated
AHS Cancer Control Alberta
National Cancer Institute (NCI)
Aposense Ltd.
Medical University Innsbruck
Poniard Pharmaceuticals